Syed Shabir Ahmad (PharmD) #DiabetesCare #Endocrinology #InsulinIcodec #Pharmacology #MedEd #MedicalEducation #HealthcareInnovation #LinkedInLearning To view or add a comment, sign in GLP-1 agonist prescribers need to know
The development was abandoned after this result
Frhbeck, G., Mndez-Gimnez, L., Fernndez-Formoso, J.-A., Fernndez, S
Jurcau A (2021) Insights into the pathogenesis of neurodegenerative diseases: focus on mitochondrial dysfunction and oxidative stress
doi: 10.1146/annurev-nutr-082117-051732 12
GLP-1 peptides like Semaglutide and Tirzepatide target this biological mismatch by influencing hunger-regulating pathways and supporting healthier metabolic rhythms